360° Coverage : Wag The Dog Stock Investing

2 Updates
Wag The Dog Stock Investing

Wag The Dog Stock Investing

Jan 10 2014, 3:43pm CST | by

The dog and tail people are at it again. DATs, I call them. These are the financial advisors who say, “Don’t let the tax tail wag the dog. Taxes should not be your primary reason for buying or...

Filed under: news

 
 
 

40 weeks ago

Wag The Dog Stock Investing

Jan 10 2014, 3:43pm CST | by

The dog and tail people are at it again. DATs, I call them. These are the financial advisors who say, “Don’t let the tax tail wag the dog. Taxes should not be your primary reason for buying or selling something.”

There are a lot of DATs. I estimate 320,000 people have, in the past month, mentioned tax tails in a canine context.  (WSJ subscribers: Find the dog tail in today’s online edition.)

The DATs are wrong. Taxes should be at the top of your mind when you do a trade—in a taxable account, that is. In a tax-deferred IRA, of course, trading doesn’t affect your tax bill.

Taxes are one aspect of investing that you can control. You can add tens of thousands of dollars to your retirement stake by understanding tax rules. You don’t have to be lucky. You don’t have to be a genius. You just have to know a few principles, like the ones that say you should let winners ride and you should harvest losses.

Can you add value by figuring out which stocks are going to go up? Or by sidestepping losses? Probably not. The average investor is no more skilled at stock picking than the average monkey.

Perhaps you have persuaded yourself that you are among the exceptions. There’s a small chance that you are right. There’s a high probability that you are in the large population of Americans (mostly male) who overestimate their stock-picking ability.

DATs have stories that go like this:

“One of my clients got into Blackberry at $12. He rode it up to $93. I told him the stock was getting ahead of itself and he should take some money off the table. He didn’t want to pay the capital gain taxes. Now look where he is.”

So? What about the guy who bought Apple at $12, saw it shoot to $60 and decided it was overpriced? He didn’t want to pay the taxes. He still owns the stock.

Suppose you have two stock positions worth $10,000. You bought one at $11,000. You bought the other for $6,000. You need $10,000 of cash. My advice: Sell the loser. You now have a $1,000 capital loss that you can use to lower your taxes. Hang on to the winner until you die.

At which point the DATs will come out of the woodwork and say that my advice will have investors buying at tops, selling at bottoms and missing the rebounds.

With this, DATs are clinging to a belief that stocks that have fallen have a particularly good chance of going back up, while stocks that have risen are particularly likely to fall.

To which I answer: If this is true, why are you wasting your life dispensing tax advice? You could start a hedge fund. Buy the 300 stocks that went down the most last year, and short the 300 that went up the most. You could make maybe a billion dollars, with no effort.

If individual stocks don’t regress to a mean, still the market as a whole might have that tendency. One could argue that the market is likely to rebound after a bad stretch, or to pull back after a decade of abnormally high returns.

So there is some validity to the warning that avid loss harvesting could have you exiting stocks when they are cheap. There’s an easy cure for this problem. If you sell for a loss, buy something else. You could sell three gold mining stocks and then buy a gold-mining fund. Sell Chevron and buy Exxon. If you are really in love with the original positions, wait 31 days (as mandated by the tax code’s wash sale rule) and go back to what you had.

Rebound regret occurs when the stock you sold for a loss recovers during the month you’re on the sidelines. This is a particularly painful condition. You can minimize the risk of suffering it by doing your loss harvesting in batches. Stochastic loss harvesting, I call it.

Let’s suppose you have six stocks that have cost you money. (You may be sitting on nothing but winners at the moment, but the day will come when you are looking at a column of red ink.) Sell A, B and C, and invest the proceeds by doubling up your positions in D, E and F. Thirty-one days later, sell your old positions in D, E and F and invest in A, B and C.

Maybe DEF will underperform ABC during the wash-sale wait, but probably not by much, and of course the reverse phenom is equally likely. If the market stays flat you’ll be back where you started but you’ll have six capital losses to claim.

Stop listening to the DATs. Spend more time thinking about how taxes affect your results, and less time trying to outguess the market.

Here are some articles about how smart investors lower their tax bills:

How Retirees Pay Zero Taxes

Smart Kiddies Duck Tax

A Roth Conversion Formula

Young Google Employee With A Clever 401(k) Move

Source: Forbes Business

 
Update
2

7 weeks ago

Khazanah throws MAS RM6b lifeline

Aug 29 2014 5:01pm CDT | Source: Business Times Singapore

August 30, 2014 1:15 AMKHAZANAH Nasional will inject RM6 billion (SS$2.4 billion) over three years to resuscitate loss-making Malaysia Airlines (MAS) under a recovery plan that includes even an Act of Parliament. Other key moves are migrating its operations, assets and liabilities to a new company (NewCo) and slashing the workforce of 20,000 by 30 per cent. ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 
Update
1

7 weeks ago

MAS posts loss of RM307m for Q2

Aug 28 2014 5:00pm CDT | Source: Business Times Singapore

August 29, 2014 1:13 AMMALAYSIA Airlines (MAS) registered a loss of RM307 million (S$122 million) for the second quarter to end-June, but warned of worse to come in the second half when the "full financial impact of the double tragedies of ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

Spanish nurse cured of Ebola
Madrid, Oct 21 (Xinhua) Spanish nursing auxiliary Teresa Romero was pronounced cured of the Ebola virus disease according to World Health Organisation (WHO) guidelines after the results of a second test confirmed Tuesday that she no longer had the virus in her blood.
 
 
Clinical trials of Ebola vaccine start Nov 1 in Switzerland
Geneva, Oct 21 (IANS/EFE) The World Health Organisation (WHO) announced Tuesday that it will begin clinical trials Nov 1 in Switzerland of one of the two anti-Ebola vaccines currently under development.
 
 
Colombia to launch world's first floating gas liquefaction plant
Bogota, Oct 21 (IANS/EFE) The world's first floating gas liquefaction plant is due to begin operating next year off the coast of northern Colombia under a pact between Canada-based Pacific Rubiales Energy and Belgian shipbuilder Exmar.
 
 
Paralysed man walks again after pioneering cell therapy
London, Oct 21 (IANS/EFE) A paralysed man has been able to walk again after therapy that involved transplanting cells from his nasal cavity into his spinal cord, the BBC reported Tuesday.
 
 
 

Latest from the Network

Keira Knightley was 'a goody two-shoes'
Keira Knightley was ''a goody two-shoes'' when she was younger. The 29-year-old actress claims she was a ''boring'' well-behaved child and never skipped school because she didn't want to upset her parents or teachers....
Read more on Celebrity Balla
 
Kat Dennings is in love with Kim Kardashian
Kat Dennings thinks Kim Kardashian's butt is ''amazing.'' The '2 Broke Girls' actress was ''very nervous'' when the 'Keeping Up with the Kardashians' star filmed a cameo for the show's 80th episode and was too shy to...
Read more on Celebrity Balla
 
Taylor Swift doesn't 'need some guy' for inspiration
Taylor Swift is ''figuring out how to cope'' with life on her own. The 'Shake It Off' hitmaker hopes her upcoming album, '1989,' will prove she doesn't ''need some guy'' to help her ''make a great record'' or to feel...
Read more on Celebrity Balla
 
Sarah Hyland is 'great'
Sarah Hyland says she is ''great'' after obtaining a restraining order against her ex-boyfriend. The 'Modern Family' star is happy to be focusing on her career again after a judge recently granted her a three-year...
Read more on Celebrity Balla
 
India re-elected to UNHRC for two years
United Nations, Oct 21 (IANS) India was Tuesday re-elected to the United Nations Human Rights Council (UNHRC) for the term 2015-2017 in a keenly contested election in the UN General Assembly in New York. Other...
Read more on Politics Balla
 
Spanish nurse cured of Ebola
Madrid, Oct 21 (Xinhua) Spanish nursing auxiliary Teresa Romero was pronounced cured of the Ebola virus disease according to World Health Organisation (WHO) guidelines after the results of a second test confirmed...
Read more on Business Balla
 
Gurdwara closed in Belgium
Brussels, Oct 21 (IANS) The mayor of the town of Vilvoorde in Belgium, Hans Bonte, has ordered the closure of the local gurdwara, Guru Nanak Sahib, for one month. Belgian media Tuesday charged that the Sikh temple "...
Read more on Politics Balla
 
Air strikes kill 28 militants in Pakistan
Islamabad, Oct 21 (IANS) At least 28 militants were killed when the Pakistani army launched an air strike in the country's northwest tribal town of Datta Khel Tuesday, military said. In a statement, Inter Services...
Read more on Politics Balla
 
Report reveals large-scale torture in China's 'Black Jails'
Beijing, Oct 21 (IANS/EFE) The use of hotels and factories as clandestine prisons where thousands of people -- mostly women -- are tortured to prevent their complaints against the government from coming to light has...
Read more on Politics Balla
 
Clinical trials of Ebola vaccine start Nov 1 in Switzerland
Geneva, Oct 21 (IANS/EFE) The World Health Organisation (WHO) announced Tuesday that it will begin clinical trials Nov 1 in Switzerland of one of the two anti-Ebola vaccines currently under development. WHO Assistant...
Read more on Business Balla